Mefox

• Description :

  Mefox is a degradation product of folic acid (HY-16637) [1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Drug Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/mefox.html

• Purity :

  98.91

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(NCC2N(C)C(C(N3C2)=NC(N)=NC3=O)=O)C=C1)=O

• Molecular Formula :

  C20H23N7O7

• Molecular Weight :

  473.44

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Rudolf Moser, et al. Crystalline sodium salt of 5-methyl- (6s) -tetrahydrofolic acid. Patent, WO2018178144A1.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, sealed storage, away from moisture)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [79573-48-1]